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Abstract
Background: While the static structure of the intracellular Ca
2+ release channel, the ryanodine receptor type 1 (RyR1) has
been determined using cryo electron microscopy, relatively little is known concerning changes in RyR1 structure that
accompany channel gating. Fo ¨rster resonance energy transfer (FRET) methods can resolve small changes in protein
structure although FRET measurements of RyR1 are hampered by an inability to site-specifically label the protein with
fluorescent probes.
Methodology/Principal Findings: A novel site-specific labeling method is presented that targets a FRET acceptor, Cy3NTA
to 10-residue histidine (His) tags engineered into RyR1. Cy3NTA, comprised of the fluorescent dye Cy3, coupled to two Ni
2+/
nitrilotriacetic acid moieties, was synthesized and functionally tested for binding to His-tagged green fluorescent protein
(GFP). GFP fluorescence emission and Cy3NTA absorbance spectra overlapped significantly, indicating that FRET could occur
(Fo ¨rster distance=6.3 nm). Cy3NTA bound to His10-tagged GFP, quenching its fluorescence by 88%. GFP was then fused to
the N-terminus of RyR1 and His10 tags were placed either at the N-terminus of the fused GFP or between GFP and RyR1.
Cy3NTA reduced fluorescence of these fusion proteins by 75% and this quenching could be reversed by photobleaching
Cy3, thus confirming GFP-RyR1 quenching via FRET. A His10 tag was then placed at amino acid position 1861 and FRET was
measured from GFP located at either the N-terminus or at position 618 to Cy3NTA bound to this His tag. While minimal FRET
was detected between GFP at position 1 and Cy3NTA at position 1861, 53% energy transfer was detected from GFP at
position 618 to Cy3NTA at position 1861, thus indicating that these sites are in close proximity to each other.
Conclusions/Significance: These findings illustrate the potential of this site-specific labeling system for use in future FRET-
based experiments to elucidate novel aspects of RyR1 structure.
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Introduction
The ryanodine receptor type 1 (RyR1) is an intracellular Ca
2+
release channel that plays a central role in skeletal muscle
excitation contraction coupling. This enormous homotetrameric
protein embedded in the sarcoplasmic reticulum (SR) is part of a
macromolecular complex that includes calmodulin, FK506
binding protein 12 kDa (FKBP12), the skeletal muscle voltage
gated Ca
2+ channel isoform (Cav1.1), and cyclic AMP dependent
protein kinase [1]. RyR1 point mutations can result in human
skeletal muscle disorders such as malignant hyperthermia, central
core disease, and multiple minicore disease. Understanding the
overall structure of this macromolecular complex and how
perturbations of this structure by these mutations lead to skeletal
muscle disease are central questions in skeletal muscle biology.
In cryo electron-microscopy (EM) reconstructions, the RyR is
mushroom-shaped with four-fold symmetry reflective of the
homotetrameric arrangement of the individual subunits [2].
Regions of the RyR implicated in muscle diseases have been
localizedto this cryoEMmap via fusion ofgreen fluorescent protein
(GFP) into these elements and subsequent visualization of the
corresponding increase in mass on the cryo EM map [3,4]. In
addition, changes in RyR structure that accompany channel gating
have been determined by comparing cryo EM maps of the RyR
locked in closed and open conformations [5,6]. However, cryo EM
techniques cannot resolve fast conformational changes of the RyR
that occur as the channel gates in real-time nor can they be used to
study RyRs in solution. Thus, additional methods are needed to
perform these types of structural measurements of RyR1.
Fo ¨rster resonance energy transfer (FRET) measurements are
well-suited to examine real-time changes in RyR conformation
and thus represent a novel approach to structure-based studies of
RyR1. FRET relies upon energy transfer from a fluorophore in
the excited state (donor) to a nearby photosensitive molecule
(acceptor). The degree of energy transfer is directly dependent on
donor-acceptor distances in the range of ,2.5–10 nm and as such,
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proteins in solution [7]. In addition, FRET can reliably measure
changes in donor-acceptor distances that reflect the conforma-
tional dynamics of proteins.
FRET measurements require site-specific placement of donor
and acceptor fluorophores onto the protein(s) being studied, often
by covalent attachment at unique cysteine or lysine residues.
However, for RyR1, site-specific fluorophore labeling at these
residues is extremely difficult since this protein contains 100
cysteines and 229 lysines per subunit [8]. Thus, the first challenge
in developing FRET methods to study RyR1 structure is to site-
specifically label the protein with fluorophores suitable for FRET
measurements. One novel approach to this problem has been to
reconstitute RyR1 with fluorescently tagged RyR binding proteins,
FKBP12 and calmodulin, and then to measure FRET between
these proteins bound to RyR1 [9]. In this elegant study, distance
measurements between these bound proteins were in close
agreement with distances predicted from cryo EM localizations
of their binding sites on RyR1 [10]. However, more versatile
labeling methods are required to make FRET measurements
between locations inaccessible to RyR-associated proteins.
Recently, a site-specific labeling method has been developed
that holds great promise for use in FRET studies of RyR1. This
method utilizes the interaction between nitrilotriacetic acid/Ni
2+
(NTA) complexes and poly-histidine ‘‘tags’’ inserted into proteins
for affinity purification [11] by coupling NTA to fluorescence
acceptors [12] in order to target these molecules to His tags
introduced into proteins. Using this method, the structures of the
serotonin receptor [13], the CAP DNA-binding protein [12] and
the NK1 tachykinin receptor [13] have been mapped using
FRET. NTA has also been coupled with quantum dots [14], biotin
[15], and conformationally sensitive fluorophores [16] to site-
specifically attach these substances to His-tagged proteins.
In the present study, this site-specific labeling method has been
adapted for labeling RyR1 with Cy3, which can then accept
fluorescence energy from GFP fused into the RyR1 primary
sequence. This study outlines the procedures for synthesis and
testing of the Cy3NTA labeling reagent as well as the construction
of His-tagged GFP-RyR1 fusion proteins suitable for FRET. In
addition, this study details FRET measurements in intact RyRs
using this site-specific labeling method.
Methods
Cy3NTA Synthesis and Purification
Cy3NTA was synthesized via incubation of 50 mM N-(5-
amino-1-carboxypentyl)iminodiacetic acid (Dojindo Molecular
Technologies, Rockville, MD) with 1 mM Cy3-bis-succinimidyl
ester (GE Healthcare Biosciences Corp., Piscataway, NJ) in 0.2 M
NaCO3 pH 9.0 buffer for 1 hr at room temperature in the dark.
The reaction mixture was then spotted on a silica gel plate and
resolved by thin layer chromatography (TLC) using a solvent
system comprised of 33:21:6 NH4OH:ethanol:water [12]. The
TLC plate was dried and examined directly for products
(Fig. 1). Cy3NTA (Rf=0.81) was scraped and extracted with
60% methanol. Yield as determined spectrophotometrically
(Cy3 e550=150,000 M
21 cm
21) was typically 40% of starting
material. NTA conjugation affected neither absorption nor
fluorescence emission of Cy3 (data not shown). Cy3NTA was
dried and stored at –80 C in individual aliquots each containing
10 nmoles of product. Before use, the two NTA groups of
Cy3NTA were charged with 20 nmoles of NiCl2 in water to form
a stock solution comprised of 500 mM Cy3NTA and 1 mM NiCl2
used for Cy3NTA titrations in functional assays.
GFP Synthesis
Oligonucleotides encoding His6 or His10 tags were inserted into
the 59 end of the cDNA encoding GFP from Aequorea coerulescens
(AcGFP; Takara BIO, Mountain View, CA) using standard
molecular biology techniques. GFP was expressed in One-
ShotBL21Star(DE3) E. Coli bacteria (Invitrogen, Carlsbad, CA)
after induction with 0.4 mM isopropyl thiogalactoside. Bacterial
lysates obtained by sonication on ice in a buffer containing 50 mM
Na2HPO4, 300 mM NaCl, pH 8.0 were incubated at 4C for 3
days to allow complete maturation of the GFP chromophore.
In vitro GFP Fluorescence Measurements
In vitro measurements of GFP fluorescence were performed on a
LS55 luminescence spectrometer (PerkinElmer, Waltham, MA) in
buffer consisting of 50 mM Na2HPO4, 300 mM NaCl, pH 8.0 in
a stirred quartz microcuvette at room temperature. GFP
fluorescence was observed via excitation of the sample with
475 nm light and monitoring emission at 510 nm. Raw fluores-
Figure 1. TLC analysis and structure of Cy3NTA. (A) Products from reactions consisting of Cy3-bis-succinimidyl ester alone (lane 1), Cy3-mono-
succinimidyl ester and AB-NTA (lane 2), and Cy3-bis-succinimidyl ester and AB-NTA (lane 3) separated by TLC as described in Methods. Arrow
indicates Cy3NTA used for FRET studies. Rf=relative index of mobility. (B) Predicted structure of Cy3NTA. Locations of Cy3 and the two NTA/Ni
2+
moieties are indicated.
doi:10.1371/journal.pone.0007338.g001
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then expressed as fraction of initial fluorescence (i.e. F/F0).
Cy3NTA titration data was fitted using:
F~F0{E1
.
1z Kd= Cy3NTA ½  ðÞ
h
     
to determine F0 (initial GFP fluorescence), h (Hill coefficient), Kd
(dissociation constant), and E (level of FRET between GFP and
Cy3).
Fo ¨rster Distance Calculations
The Fo ¨rster distance (at which 50% energy transfer occurs)
between GFP and Cy3 was calculated from the degree of overlap
between the GFP emission spectrum and Cy3 absorption spectrum
(Fig. 2a) using:
Ro in nm ðÞ ~9:79 X102: k
2n{4QDJ l ðÞ
   1=6
where the orientation factor, k
2=0.66 (assuming random
orientation of the donor and acceptor dipoles), refractive index
of the medium (assumed to be water) between donor and acceptor,
n=1.4, quantum yield of GFP donor QD=0.79 and overlap
integral J(l)=5.21610
213 M
21 cm
3 calculated using:
J l ðÞ ~
ð
FD l ðÞ :eA l ðÞ :l
4dl
where eA(l) and FD(l) represent the molar extinction coefficient of
the acceptor (in cm
21 M
21) and the normalized donor emission
(in %) at wavelength l (in cm), respectively.
RyR1 cDNA Cloning
Primers containing SanD I sites were used to amplify cDNA
encoding AcGFP using polymerase chain reaction (PCR). The 39
primer also encoded a glycine rich segment: GGGGSGGGG. The
resulting 0.75 kB product cloned into TOPO TA vector (Invitro-
gen) was confirmed using DNA sequencing. After cleavage with
SanD I, the AcGFP cDNA was inserted into a unique SanDI
restriction site introduced at the 59 end of the rabbit RyR1 cDNA
to create GFP-RyR1(-His). To create GFP(618)-RyR1, primers
containing Bgl II sites that each encoded the glycine rich segment
indicated above were used to amplify cDNA encoding AcGFP
using PCR. After cloning into TOPO TA and sequence
verification, the AcGFP cDNA was inserted into a naturally
occurring Bgl II site corresponding to amino acid position 618 in
Figure 2. Cy3NTA quenches fluorescence of a His-tagged GFP. (A) Normalized GFP emission (green, lEx=476 nm) and Cy3NTA absorbance
(red) spectra. (B) Time-based measurements of GFPHis6 fluorescence normalized to initial intensity (F0). Arrow indicates point of addition of either
4 mM NiCl2 (blue trace), Ni/NTA (green) or Cy3NTA (red). Arrowhead indicates addition of 5 mM EDTA. (C) Time-based fluorescence measurements of
GFP either lacking (-His; blue trace) or containing an N-terminal His tag with either 6 (green) or 10 (red) residues. Arrowheads indicate additions of
Cy3NTA at the (mM) concentrations indicated. Arrow indicates addition of 5 mM EDTA. (D) Detailed fluorescence quenching curves for Cy3NTA
binding to each of the 3 GFP constructs. Values are averages of GFP fluorescence after addition of Cy3NTA. Quenching data for His-tagged GFP
constructs were fit as described in Methods.
doi:10.1371/journal.pone.0007338.g002
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the 59 or 39 end of GFP were used to amplify AcGFP and the
resulting product was cloned into the SanD I site at amino acid
position 1 to create GFP-RyR1 (N-term His) and GFP-RyR1
(19His) respectively. A linker encoding a His10 tag was inserted into
a naturally occurring Bgl II site corresponding to amino acid
position 1861 to create GFP-RyR1 fusion proteins with a His10 tag
at this site.
Cell Culture and Transfection
HEK-293T cells were grown in Dulbecco’s modified Eagles
medium supplemented with 10% fetal calf serum (Hyclone),
2 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml
streptomycin sulfate. Cells were transfected with cDNAs encoding
GFP-tagged RyR1 proteins as follows: A solution consisting of
10 mg of cDNA in 300 ml of DMEM supplemented with 0.1 mg/
ml linear polyethylenimine (Polysciences Inc., Warrington, PA)
incubated for 15 min at room temperature was added to 500,000
HEK293T cells. After 24 hours, cells were transferred to 16-well
slides (Nunc, Rochester, NY) precoated with ECM reagent (Sigma
Aldrich, St. Louis, MO) diluted 1:2 in DMEM and cells were then
utilized for experiments 24 hr later.
Ca
2+ Imaging
HEK-293T cells expressing RyRs were loaded with 5 mM Fura-
2 AM (Invitrogen) for 30 min at 37C in ‘‘imaging buffer’’
consisting of 125 mM NaCl, 5 mM KCl, 1.2 mM MgSO4,2m M
CaCl2, 6 mM glucose and 25 mM HEPES, pH 7.4. After washing
and a further 30 min incubation at 37C to complete de-
esterification of Fura-2, cells were imaged at 406 magnification
using a Zeiss Axiovert 200 epifluorescence microscope (Thorn-
wood, NY) interfaced with a Hyperswitch Ca
2+ imaging system
(Ionoptix Corp., Milton, MA). Cells were perfused with a graded
series of caffeine concentrations in imaging buffer using a
Valvebank 8-channel perfusion system (Automate Scientific,
Berkeley, CA) and changes in intracellular Ca
2+ were recorded
as changes in Fura-2 fluorescence ratio (Emission=510 nm) when
the cells were alternately excited at 340 and 380 nm at 60 Hz.
Normalized Ca
2+ transients were quantified from the area under
each transient using Ionoptix analysis software. This data plotted as
a function of caffeine concentration was fit to a sigmoidal dose-
response function (variable slope) to determine EC50 values that
were compared using 1-way analysis of variance (ANOVA) using
Prism 4 software (Graphpad Inc., San Diego, CA).
FRET Imaging
HEK-293T cells expressing GFP-RyR1 fusion proteins were
permeabilized for 30 min at room temperature in ‘‘FRET buffer’’
comprised of 125 mM NaCl, 5 mM KCl, 6 mM glucose, 25 mM
HEPES pH 7.6 supplemented with 0.02% saponin. Cells were
imaged on a Leica TCS SP5 confocal microscope (Mannheim,
Germany) via illumination at 476 nm and recording GFP and Cy3
fluorescence using PMT windows set at 500–525 nm and 550–
610 nm, respectively. Image data was recorded as a series of
confocal Z-stacks comprised of 30 images recorded over a 100 mm
distance. Fluorescence for a given cell was quantified from the
peak fluorescence value recorded from a region of interest placed
on that cell. GFP fluorescence recorded 60 min after addition of
Cy3NTA was normalized to resting fluorescence to determine F/
F0 values for each cell which were then averaged for all cells at
each [Cy3NTA]. Data plotted as a function of [Cy3NTA] was fit
as described for the Ca
2+ imaging data (see above). Energy transfer
efficiency (E) was calculated using
E~1{F=F0 at saturatinglevels of Cy3NTA:
NTA-agarose Column Chromatography
HEK-293T cells expressing GFP-RyR1 fusion proteins
(,500,000 total cells) were sonicated in FRET buffer supplement-
ed with a commercial mixture of common protease inhibitors
(Roche Applied Sciences, Mannheim, Germany) lacking divalent
metal ion chelators. The resulting lysates were fractionated on a
0.2 ml NTA-agarose column (Qiagen, Valencia, CA) pre-equili-
brated in FRET buffer. Individual 150 ml fractions were collected
in a 96-well polystyrene plate after column washes with buffer
alone, followed by FRET buffer containing 30 mM imidazole and
300 mM imidazole.
After a 1 hr incubation to allow protein adsorption, RyR
content in individual fractions was quantified as follows. Plates
were washed with ‘‘TBS-T buffer’’ consisting of 50 mM Tris-HCl,
150 mM NaCl, 0.1% Tween-20 pH 7.4 and then blocked with
5% nonfat milk in TBS-T for 1 hr at RT. After washing with
TBS-T, plates were incubated 1 hr in 34C anti-RyR primary
antibody (Developmental Studies Hybridoma Bank, Iowa City,
IA) diluted 1:200 in TBS-T, followed by washing in TBS-T and
1 hr incubation in goat anti-mouse HRP conjugated secondary
antibody (Invitrogen) diluted 1:1000 in TBS-T. After washing,
plates were incubated in TMB substrate (Thermo Scientific,
Rockford, Il) followed by neutralization with 0.15 N H2SO4. TMB
absorbance (lmax=450 nm) was quantified on a Tecan Safire II
plate reader (Grodig, Austria).
Results
Synthesis and Purification of Cy3NTA
TLC analysis was used to examine reaction products between
Cy3-succinimidyl esters and N-(5-amino-1-carboxypentyl)imino-
diacetic acid (AB-NTA) (Fig. 1a). Cy3-bis-succinimidyl ester alone
(Bis-Cy3) ran at the solvent front (lane 1) whereas incubation of
Cy3-mono-succinimidyl ester with AB-NTA resulted in an
additional product migrating at Rf=0.86 (lane 2). Incubation of
Cy3-bis-succinimidyl ester with AB-NTA (lane 3) resulted in an
additional predominant product migrating at Rf=0.81 that was
purified and reconstituted with Ni
2+ to form the FRET acceptor,
Cy3NTA (Fig. 1b).
Functional Ttesting of Cy3NTA
To determine if Cy3NTA could act as a His-tag specific FRET
acceptor, in vitro fluorimetry was used to determine the ability of
this compound to quench fluorescence of His-tagged GFP via
FRET. Overlap between the emission spectrum of GFP and the
absorbance spectrum of Cy3NTA (Fig. 2a) was used to calculate a
predicted Fo ¨rster distance (at which 50% energy transfer occurs) of
6.30 nm for this donor-acceptor pair. Incubation of His6-tagged
GFP with 4 mM Cy3NTA resulted in a 75% decrease in GFP
fluorescence that was completely reversed by 5 mM EDTA
(Fig. 2b). Incubation of GFPHis6 with either 4 mMN i
2+ or
4 mMN i
2+/NTA did not enhance GFP quenching (Fig. 2b) and
no GFP quenching was observed in the presence of Cy3 alone or
when Cy3NTA was added in the presence of 150 mM imidazole
(data not shown). While Cy3NTA did not quench fluorescence of
GFP lacking a His tag (Fig. 2c; blue trace), Cy3NTA did quench
GFP containing a His6 tag in a concentration dependent manner
that could be reversed by EDTA (Fig. 2c; green trace).
Lengthening the His tag to 10 residues enhanced the degree of
quenching and the apparent affinity of Cy3NTA binding (red
FRET Measurements of RyR1
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GFPHis6 or GFPHis10 fluorescence (Fig. 2d) yielded apparent
affinities of 1.01 and 0.11 mM, respectively and degrees of
quenching of 72% and 88% respectively.
Levels of Ni
2+/NTA up to 100 mM had no effect on RyR1
activity, as indicated by [
3H]ryanodine binding analysis of heavy
SR vesicles from skeletal muscle (data not shown). This data
suggests that Ni
2+, when complexed with NTA, does not affect
RyR1 function.
Construction, Expression and Functional Testing of His-
Tagged GFP-RyR1 Fusion Proteins
To determine if Cy3NTA could be used for FRET-based
structuralmeasurementsofRyR1,GFP wasfused tothe N-terminus
of RyR1 to act as a fluorescence donor. Then, three GFP-RyR1
constructs were created (Fig. 3a)that eitherlacked a Histag (-His) or
contained a His10 tag at either the N-terminus (N-term His) or
between the fused GFP and RyR1 (19His). Expression of these
constructs in HEK-293T cells was verified via confocal microscopy
by observing GFP fluorescence that co-localized with anti-RyR
immunoreactivity (data not shown). The function of these fusion
proteins was tested using Fura-2 based Ca
2+ imaging (Fig. 3b). The
RyR activator, caffeine, triggered Ca
2+ release in HEK-293T cells
expressing either wtRyR1 or each of the 3 GFP-RyR1 fusion
proteins whereas untransfected cells did not respond to caffeine.
The EC50 for caffeine activation for each GFP-RyR1 fusion
construct was unchanged compared to wildtype RyR1 (Fig. 3c).
The inserted His10 tags must be present on the surface of RyR1
in order for Cy3NTA to bind. The surface exposure of the inserted
His10 tags was determined using NTA-agarose affinity chroma-
tography (Fig. 4). Lysates prepared from HEK-293T cells
expressing these RyR constructs were fractionated on an NTA-
agarose column washed with 30 mM imidazole (to elute weakly
bound proteins) and 300 mM imidazole (to elute tightly bound
proteins). Both His-tagged GFP-RyR1 fusion proteins eluted with
300 mM imidazole, thus indicating that these constructs bound
tightly to the column. In contrast, neither wtRyR1 nor GFP-
RyR1(–His) were eluted with 300 mM imidazole thus suggesting
that these proteins did not bind tightly to the column.
FRET Measurements of His-Tagged GFP-RyR1 Fusion
Proteins Using Cy3NTA
The ability of Cy3NTA to quench fluorescence of GFP-RyR1(N-
term His) expressed in HEK-293T cells was determined using
confocal microscopy (Fig. 5). After incubation with 2 mM Cy3NTA,
GFP-RyR1(N-term His) fluorescence decreased by 75%, whereas
Cy3 fluorescence appeared in both transfected and untransfected
cells. After photobleaching Cy3 for 20 min, GFP-RyR1(N-term
His) fluorescence recovered to 85% of its initial level.
GFP-RyR1(N-term His) fluorescence was quenched in a
concentration dependent manner by Cy3NTA that could be
blocked by preincubation with 5 mM EDTA (Fig. 6a) or with
150 mM imidazole (data not shown). Cy3NTA quenched GFP-
RyR1(N-term His) and GFP-RyR1(19His) to similar degrees
(76.7% and 76.5% respectively) whereas this compound quenched
GFP-RyR1(-His) by only 14.6% (Fig. 6b). The apparent affinity
for Cy3NTA binding to GFP-RyR1(N-term His) and GFP-
RyR1(19 His) was 0.56 and 0.11 mM, respectively.
To determine if this system could be used to measure FRET
between internal sites of RyR1, additional fusion proteins were
created that contained a His10 tag at amino acid residue 1861 in
divergent region 3 (DR3) [17] and GFP at either the N-terminus
(to create construct GFP(1)DR3His) or at amino acid position 618
(to create construct GFP(618)DR3His (Fig. 7a)). These constructs
could be activated by caffeine similar to wtRyR1 in Ca
2+ imaging
experiments and the His10 tag was surface exposed as determined
using NTA-agarose column chromatography (data not shown).
Cy3NTA quenched GFP(1)DR3His to a similar extent (20.1%)
compared to GFP-RyR1(-His) whereas Cy3NTA quenched
GFP(618)DR3His by 52.7% (Fig. 7b). Comparison of quenching
by 1 mM Cy3NTA of GFP-RyR1 fusion constructs with GFP at
either position 1 or 618 that lacked or contained a His10 tag at
Figure 3. GFP-RyR1 fusion proteins release Ca
2+ in response to
caffeine stimulation. (A) GFP-RyR1 fusion constructs tested for FRET.
Bars represent amino acid sequence of GFP (green) and RyR1 (black).
The sequence of the glycine rich linker between GFP and RyR1 as well
as positions of inserted His10 tags are shown. Scale indicates RyR1
amino acid number. (B) Caffeine-induced Ca
2+ transients in HEK-293T
cells expressing RyR1 constructs measured using Fura-2 based Ca
2+
imaging. A graded series of caffeine concentrations were perfused at
the times and concentrations indicated (black bars). Individual
representative traces indicate changes in Fura-2 fluorescence excitation
F340/F380 ratio. Ctrl indicates untransfected cells. Calibration bar=0.2
340/380 ratio units vs. 50 s. (C) Normalized caffeine dose response
curves for the indicated constructs. Values represent mean +/2 S.E.M.
for 19–22 cells per construct. EC50 values were calculated from the
midpoint of these curves as described in Methods. No statistical
difference (1-way analysis of variance (ANOVA); p,0.05) between EC50
values was observed.
doi:10.1371/journal.pone.0007338.g003
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GFP(618)DR3His construct (Fig. 7c).
Discussion
Site-Specific Labeling System
The Cy3NTA-based labeling method detailed in this study takes
advantage of the well-characterized interaction between Ni
2+
atoms and imidazole side chains of histidine residues that is used
for purification of His-tagged proteins [11]. In this study, Cy3 was
coupled to two NTA residues to create Cy3NTA. This compound
had a higher apparent binding affinity for binding His tags (0.1–
0.5 mM in this study and [12]) compared to mono-NTA
fluorophore conjugates which have apparent Kd values between
1–4 mM [13,18]. In addition, lengthening the His tag from 6 to 10
residues further enhanced binding affinity, most likely by
increasing the probability of a productive collision between the
NTA/Ni
2+ group and the His tag.
An advantage of this labeling system is site-specificity. Cy3NTA
can be targeted to virtually any desired region of a protein that
contains a surface exposed His tag. For RyR1, this method is well
suitedforsite-specificlabelingexperimentsforthe followingreasons.
1) Nonspecific binding of Cy3NTA to endogenous histidines in
RyR1 should be minimal since this protein contains only one
segment with twoconsecutivehistidines andnosegment longerthan
2 [8]. 2) Neither wildtype RyR1 nor GFP-RyR1 lacking a His tag
bound to the NTA-agarose column, thus indicating that these
proteins lack Ni/NTA binding sites and thus should not be able to
bind Cy3NTA. 3) All His-tagged GFP-RyR1 fusion proteins bound
to the NTA-agarose column thus indicating that the introduced
His10 tags are available to bind Ni/NTA and, by extension,
Cy3NTA. 4) When His10 tags were placed in RyR1 positions
Figure 4. His-tagged GFP-RyR1 fusion proteins bind to NTA-
agarose. NTA-agarose-based fractionation of crude lysates from HEK-
293T cells expressing GFP-RyR1 fusion proteins. Columns were washed
as indicated (dotted lines). Datum points indicate relative levels of RyR
immunoreactivity in consecutive 120 ml fractions quantified by an RyR-
specific ELISA assay as described in Methods.
doi:10.1371/journal.pone.0007338.g004
Figure 5. Cy3NTA quenches GFP-RyR1 (N-term His) fluorescence via FRET. HEK-293T cells expressing GFP-RyR1 (N-term His) were examined
for GFP (panels A,C,E) and Cy3 fluorescence (B,D,E) either before (A,B) or after (C,D) a 30 min incubation with 2 mM Cy3NTA. Cy3 fluorescence was
observed both in HEK-293T cells expressing GFP-RyR1(N-term His) (asterisks) and untransfected cells. Cy3 was then selectively bleached via 20 min
illumination with 550 nm light resulting in an increase in GFP fluorescence (panel E) and a decrease in Cy3 fluorescence (F).
doi:10.1371/journal.pone.0007338.g005
FRET Measurements of RyR1
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a highdegreeof FRET was observed (Fig. 5–6).Thisresult indicates
that Cy3NTA bound to these inserted His10 tags in RyR1.
An additional advantage of this labeling system is reversibility.
After making a FRET measurement, the bound NTA-fluorophore
can be removed with either EDTA or imidazole and a new NTA-
fluorophore can potentially be applied. This approach has been
used with NTA conjugated to the fluorescent dye, Atto-647 to
examine diffusion of His10-tagged serotonin receptors in the
plasma membrane of HEK-293 cells [18]. In the FRET-based
assay system developed in the present study, a second fluorescence
acceptor with a different R0 value could be added to calibrate
distance measurements with Cy3NTA.
Finally, this labeling system provides a high degree of versatility
due to the relative ease in construction of new NTA-based probes.
Numerous such probes have already been created including NTA
coupled with either quantum dots, conformationally sensitive
fluorescent probes, biotin or numerous fluorophores with varying
spectral properties [14–16,19,20]. Thus, His-tagged RyRs can be
potentially probed with novel NTA-based fluorophores for
numerous downstream applications.
FRET System
In this study, GFP was chosen as a donor fluorophore in the
FRET measurements due to its high quantum yield and lack of
susceptibility to quenching via either collisional or static
mechanisms [21]. The N-terminal domain of RyR1 was selected
as a site to attach the GFP donor because previous studies have
indicated that GFP fusion at this site does not affect RyR1 activity
Figure 6. Cy3NTA quenches His-tagged GFP-RyR1 fluorescence
in a concentration-dependent manner. (A) Concentration depen-
dence of Cy3NTA quenching of GFP-RyR1 (N-term His) fluorescence. The
indicated Cy3NTA concentrations were added to HEK-293T cells
expressing GFP-RyR1 (N-term His) at the time point indicated
(arrowhead) and the change in GFP fluorescence normalized to initial
fluorescence (F/F0) was measured. Pre-incubation with 5 mM EDTA (top
trace) abolished fluorescence quenching by Cy3NTA. (B) Cy3NTA
concentration dependence of quenching of the indicated GFP-RyR1
fusion proteins expressed in HEK-293T cells. Values represent mean +/2
S.E.M. for 7–14 cells. EC50 and FRET efficiency values were determined
from these curves as described in Methods.
doi:10.1371/journal.pone.0007338.g006
Figure 7. Cy3NTA can be used to measure FRET between
internal sites on RyR1. (A) GFP-RyR1 fusion constructs containing a
His10 tag in divergent region 3 at amino acid residue 1861. Bars
represent amino acid sequence of GFP (green) and RyR1 (black). For
construct GFP(618)DR3His, GFP inserted at amino acid residue 618 was
flanked by poly-glycine segments as indicated in Methods. Scale
indicates RyR1 amino acid number. (B) Cy3NTA concentration-
dependence of quenching of GFP(1)DR3His (green trace) and
GFP(618)DR3His (purple) expressed in HEK-293T cells. Data was fit to
determine EC50 and the level of energy transfer (E) as described in
Methods. (C) Degree of quenching of the indicated GFP-RyR1 fusion
proteins by 1 mM Cy3NTA. Asterisk indicates significant level of
quenching (p,0.01) relative to GFP-RyR1 (-His) as determined using
1-way ANOVA followed by a Dunnett’s post test.
doi:10.1371/journal.pone.0007338.g007
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‘‘clamp’’ domain in the corners of the RyR1 homotetramer
approximately 19.7 nm from each other [22], a distance too far
for cross-FRET between RyR subunits to occur using the GFP-
Cy3 FRET pair. GFP was fused to RyR1 using flexible glycine-
rich linkers to permit free rotation of the GFP chromophore,
which is an important consideration in FRET measurements that
require randomization of donor and acceptor fluorescence dipoles.
There is little question that GFP fused to RyR1 is quenched by
Cy3NTA via FRET due to the fact that: 1) The GFP
chromophore is shielded within a ‘‘beta-can’’ structure [21] that
should prevent quenching of GFP fluorescence by Cy3 via non-
FRET mechanisms. 2) While binding of Ni
2+ to the His10 tags
could potentially quench GFP fluorescence via FRET [24,25], this
is unlikely because neither Ni
2+ alone nor Ni
2+ complexed with
NTA quenched GFPHis6 fluorescence (Fig. 2b). 3) In the cell-
based FRET measurements, GFP-RyR1 (N-term His) fluorescence
recovered after photobleaching Cy3 (Fig. 5). This technique is
commonly used to quantify FRET in systems employing donor
and acceptor fluorescent proteins [26]. The recovery of donor
fluorescence after photobleaching of the acceptor is strong
evidence that Cy3NTA-dependent decreases in GFP fluorescence
occurs via FRET.
FRET Measurements in Intact RyRs
Equal levels of FRET (,75%) were observed between the donor
GFP fused to the N-terminus of RyR1 and the Cy3NTA acceptor
bound to His tags introduced either at the N-terminus of GFP or
between GFP and RyR1 (Fig. 6b). This findingis consistent with the
fact that the N- and C-termini of GFP (where the His10 tags were
introduced) are located on the same face of the GFP beta can [21]
and thus are approximately the same distance from the GFP donor
chromophore. This result provides strong evidence that the level of
FRET is dependent on the proximity between the donor and
acceptor chromophores introduced into RyR1.
FRET was also observed between GFP at position 618 and
Cy3NTA bound to a His10 tag adjacent to divergent region 3 at
amino acid position 1861. This level of FRET (53%) was higher
than the level of FRET observed (20%) between GFP at position 1
and Cy3NTA bound to the His10 tag at DR3. These findings are
consistent with predicted levels of FRET between these points
estimated from cryo EM maps localizing the N-terminus, amino
acid 423 and amino acid 1903 [3,22,27], positions roughly
analogous to the locations of GFP (amino acid position 1, 618)
and the His10tag (position 1861) inthe presentstudy.The estimated
distance between residue 423 and 1903 of 6.3 nm is ,2 nm closer
than the estimated distancebetween the N-terminusandaminoacid
residue 1903.The FRET measurements inthis studyalsofollow this
predicted trend in that a higher level of FRET is observed between
donor and acceptor molecules placed at amino acid residues 618 to
1861 compared to these molecules placed at residues 1 and 1861.
Conversion of these FRET levels to distances would probably be
inaccurate due to the physical dimensions of the donor (GFP:
364.5 nm) and acceptor (Cy3NTA: 361.8 nm). However, the fact
that the level of FRET increases as predicted when GFP is placed
closertotheDR3His10tagcoupledwiththeobservationthatFRET
is being measured across a distance of over 1000 amino acid
residues in the RyR1 primary sequence demonstrates the utility of
this technique in structural mapping of the RyR.
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